On September 8, a group of more than 100 national and state-based advocacy organizations sent a letter to the House and Senate Judiciary Committees urging Congress to amend H.R. 9 to preserve protections of the Hatch-Waxman Act and to avoid weakening the patents that sustain medical research. In the letter, advocates argue that the Innovation Act […]